Vcanbio Cell & Gene Engineering Corp., Ltd (SHA:600645)

SHA:600645 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 20, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	10,226	8,799	9,485	7,960	11,811	9,176
Market Cap Growth	37.23%	-7.24%	19.16%	-32.61%	28.71%	15.82%
Enterprise Value	8,855	7,548	8,212	6,852	10,829	8,338
Last Close Price	22.43	19.30	20.27	17.01	25.24	19.61
PE Ratio	117.30	87.68	89.10	70.45	76.04	-
Forward PE	60.62	48.99	48.99	48.99	48.99	48.99
PS Ratio	6.65	5.55	5.97	5.12	7.69	6.96
PB Ratio	2.78	2.40	2.50	2.18	3.34	2.62
P/TBV Ratio	3.62	3.15	3.29	2.90	4.50	3.63
P/FCF Ratio	40.51	40.39	45.08	48.92	61.13	60.12
P/OCF Ratio	32.97	30.85	31.72	30.39	36.80	37.55
EV/Sales Ratio	5.76	4.76	5.17	4.41	7.05	6.32
EV/EBITDA Ratio	35.29	28.43	29.15	27.01	47.63	42.36
EV/EBIT Ratio	69.26	46.25	59.45	47.94	87.02	89.17
EV/FCF Ratio	35.08	34.64	39.03	42.12	56.04	54.63
Debt / Equity Ratio	0.03	0.03	0.03	0.04	0.02	0.02
Debt / EBITDA Ratio	0.45	0.42	0.45	0.50	0.33	0.30
Debt / FCF Ratio	0.47	0.57	0.61	0.87	0.43	0.38
Asset Turnover	0.29	0.30	0.30	0.30	0.31	0.27
Inventory Turnover	1.96	2.07	2.04	2.15	2.11	2.04
Quick Ratio	1.48	1.47	1.49	1.36	1.24	1.23
Current Ratio	1.70	1.65	1.69	1.57	1.46	1.47
Return on Equity (ROE)	1.97%	2.40%	2.65%	2.97%	4.30%	-3.65%
Return on Assets (ROA)	1.66%	1.91%	1.61%	1.73%	1.57%	1.20%
Return on Capital (ROIC)	2.29%	2.65%	2.24%	2.41%	2.17%	1.63%
Return on Capital Employed (ROCE)	3.70%	4.30%	3.50%	3.70%	3.40%	2.60%
Earnings Yield	0.86%	1.14%	1.12%	1.42%	1.31%	-1.38%
FCF Yield	2.47%	2.48%	2.22%	2.04%	1.64%	1.66%
Payout Ratio	-	-	-	-	1.03%	-
Buyback Yield / Dilution	-0.84%	1.45%	1.69%	-0.02%	-0.17%	-4.01%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.